← Back to Search

Video Education for Diabetic Retinopathy

N/A
Waitlist Available
Led By Yao Liu, MD, MS
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre and post video testimonial intervention (up to 90 minutes)
Awards & highlights
No Placebo-Only Group

Summary

This trial will involve 1,500 Latinx patients with diabetes participating in an online survey and 20 patients in 4 focus groups. The study aims to gather initial information on how patient and clin

Who is the study for?
This trial is for Latinx individuals with diabetes. It aims to gather data on whether video testimonials can improve their understanding of eye health and trust in healthcare.
What is being tested?
The study involves an online survey and focus groups to evaluate the impact of patient and clinician video testimonials on diabetic eye screening education among Latinx communities.
What are the potential side effects?
Since this trial involves non-invasive methods like surveys and educational videos, there are no direct physical side effects expected from participation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre and post video testimonial intervention (up to 90 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre and post video testimonial intervention (up to 90 minutes) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Eye Health Literacy as measured by Compliance with Annual Diabetic Eye Exams Survey (CADEES)
Secondary study objectives
Change in Trust in Healthcare as measured by Trust in the Health Care Team (T-HCT) scale score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

5Treatment groups
Active Control
Group I: National Eye Institute video ControlActive Control1 Intervention
Group II: Patient Only TestimonialsActive Control1 Intervention
Group III: Patient plus Clinician Combined TestimonialsActive Control1 Intervention
In addition to being randomized for online survey participants, focus groups will view patient plus clinician combined testimonials.
Group IV: Clinician Only TestimonialsActive Control1 Intervention
Group V: Pre-video questionnaire-only ControlActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,230 Previous Clinical Trials
3,198,299 Total Patients Enrolled
5 Trials studying Diabetic Retinopathy
8,246 Patients Enrolled for Diabetic Retinopathy
National Eye Institute (NEI)NIH
555 Previous Clinical Trials
1,405,866 Total Patients Enrolled
50 Trials studying Diabetic Retinopathy
41,319 Patients Enrolled for Diabetic Retinopathy
Yao Liu, MD, MSPrincipal InvestigatorUniversity of Wisconsin, Madison
2 Previous Clinical Trials
2,010 Total Patients Enrolled
2 Trials studying Diabetic Retinopathy
2,010 Patients Enrolled for Diabetic Retinopathy
~1017 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top